Nitric oxide (NO) is derived from the oxidation of one of the terminal guanidine nitrogens of L-arginine (1, 2) . The reaction is catalyzed by nitric oxide synthase (NOS), which exists in several isoforms. Constitutive NOS is expressed by endothelial cells and neurons. It is activated by an increase in intracellular Ca 2+ and produces low levels of NO. This isoform of NOS is involved in the regulation of neurotransmission, vascular tone, and platelet aggregation. Inducible NOS (iNOS) is expressed by many cell types, especially macrophages. This isoform is induced by inflammatory cytokines, such as tumor necrosis factor-␣/␤, interleukin 1␣/␤, and interferon alfa, beta, and gamma. The activation of iNOS results in the production of high levels of NO, which is associated with a cytotoxic reaction against pathogens and tumor cells (1-4). As a major cytotoxic mediator secreted by activated macrophages and endothelial cells, NO has been shown to be responsible for the destruction of tumor cells in vivo and in vitro (5) (6) (7) . The production of endogenous NO is associated with apoptosis of tumorigenic cells (8, 9) , and transfection of highly metastatic melanoma cells with the iNOS gene suppressed tumorigenicity and abrogated production of metastasis, thereby proving a causal relationship between production of endogenous NO and cell survival (10) .
In vitro cell death is associated with high levels of NO, with the extent of cytotoxicity depending on the cell type and other cytotoxic molecules involved (4, 11) . The in vitro use of NO donor compounds, e.g., sodium nitroprusside or NO gas, suggests that this molecule is indeed highly toxic to cells (2, 4, 11) . The in vivo induction of iNOS is associated with regression of established liver metastases produced by murine M5076 reticulum cell sarcoma by a mechanism involving production of NO from within the tumor cells (12) . Whether the regression of the metastases was due to activation of the iNOS gene in every tumor cell or whether NO-producing M5076 cells could also kill bystander (non-iNOS activated) cells remained unclear.
The purpose of this study was to provide direct evidence of a causal relationship between the production of NO by effector cells and the induction of cell death in target cells (bystander cells). We used mouse melanoma cells genetically engineered to produce NO to study for the first time if NO-producing cells undergo autolysis and produce lysis of bystander cells under both in vitro and in vivo conditions. iNOS Gene iNOS complementary DNA from mouse macrophages (13) was from Drs. Carl Nathan and Qiao-Wen Xie (Cornell University Medical College, New York, NY). The full-length piNOS-L8 gene encodes an enzymatically active iNOS protein, whereas the C-terminal-truncated piNOS-S2 gene encodes an enzymatically inactive iNOS protein (14) .
Materials and Methods

Reagents
Cell Lines and Culture Conditions
The original K-1735 melanoma induced in a C3H/HeN mouse by exposure to UV light followed by painting with croton oil was from Dr. Margaret Kripke, The University of Texas M. D. Anderson Cancer Center, Houston (15) . The parental tumor was cloned in vitro by a double-dilution method (16) . In this study, we used two highly metastatic clones: C4 and M2 (17) . CT-26 is a murine colon carcinoma syngeneic to BALB/c mice (18) . UV-2237 fibrosarcoma is a UV-induced progressor tumor syngeneic to C3H/HeN mice (19) . RENCA is a murine renal cell cancer syngeneic to BALB/c mice (20, 21) . The B16-BL6 melanoma is a highly invasive and metastatic variant line syngeneic to C57BL/6 mice (22) .
All cell lines were maintained in T-75 plastic flasks (Corning Costar Corp., Cambridge, MA) as adherent monolayers in MEM supplemented with 5% FBS, sodium pyruvate, nonessential amino acids, L-glutamine, and a twofold vitamin solution. Cell cultures were incubated in 5% CO 2 -95% air at 37°C. All cultures were free of Mycoplasma and the following murine viruses: reovirus type 3, pneumonia virus, K virus, Theiler's encephalitis virus, Sendai virus, minute virus, mouse adenovirus, mouse hepatitis virus, lymphocytic choriomeningitis virus, ectromelia virus, and lactate dehydrogenase virus (assayed by M. A. Bioproducts).
Transfection Procedures and Selection of Clones
Murine K-1735 C4.parental (C4.P) cells were cotransfected with pcDNAI plasmids containing the Neo resistance gene (pcDNAI/Neo) (Invitrogen, San Diego, CA), L8 gene (enzymatically active iNOS, piNOS-L8), or the S2 gene (enzymatically inactive iNOS, piNOS-S2) (13, 14) with the use of lipofectin solution (Life Technologies, Inc. [GIBCO BRL], Gaithersburg, MD) as previously reported (10) . After G418 (Life Technologies, Inc.) selection, the individual resistant colonies were isolated and established in culture as individual lines. Transfectants were designated as C4.Neo (control), C4.S2 (truncated iNOS gene), or C4.L8 (full-length iNOS gene). To inhibit production of NO, all lines were maintained in L-arginine-free MEM-NMA/G418 and frozen after one to three in vitro passages. Sigma Chemical Co. (23) . The cells were incubated for 2 hours in medium containing 0.42 mg/mL MTT, the medium was removed, and the cells were lysed in dimethyl sulfoxide. The conversion of MTT to formazan by metabolically viable cells was monitored by a 96-well microtiter plate reader at 570 nm (Dynatech Laboratories, Inc., Chantilly, VA) (23) . Percent cytostasis, which represents inhibition of cell proliferation, was calculated by the formula: 4 viable cells (of each line) were plated in triplicate into 96-well plates in medium with or without 3 mM NMA. After 72 hours, the supernatants were removed. The adherent cells were washed three times with HBSS and lysed with 0.1 N NaOH. The radioactivity was monitored in a beta counter. Autocytolysis was calculated according to the formula:
In Vitro Cytostasis Assay
where A is the cpm of control C4.S2.3 cells incubated in medium and B is the cpm of test cells incubated in medium with or without 3 mM NMA.
In Vitro Bystander Cytolysis Assay
Target cells (C4.P, B16-BL6, CT-26, and RENCA) in exponential growth phase were incubated for 18 hours in medium containing 0.1 Ci/mL [ 
Nitrite Analysis
The concentration of nitrite in the culture supernatants was determined by a microplate assay described by Ding et al. (24) . Briefly, 50-L samples were harvested from conditioned medium and allowed to react with an equal volume of Griess reagent (1% sulfanilamide-0.1% naphthylethylene diamine dihydrochloride-2.5%, H 3 PO 4 ) at room temperature for 10 minutes. The absorbance at 540 nm was monitored by a microplate reader. Nitrite concentration was determined by using sodium nitrite as a standard.
Mice
Specific pathogen-free female C3H/HeN mice were purchased from the Animal Production Area of the National Cancer Institute-Frederick Cancer Research and Development Center (Frederick, MD). Mice between the ages of 8 and 12 weeks were used according to institutional guidelines; they were maintained under specific pathogen-free conditions in facilities approved by the American Association for Accreditation of Laboratory Animal Care and in accordance with current regulations and standards of the U.S. Department of Agriculture, U.S. Department of Health and Human Services, and the National Institutes of Health.
Tumorigenicity
To prepare tumor cells for inoculation, cells in exponential growth phase were rinsed several times with medium containing 5 mM L-arginine before a brief exposure to 0.25% trypsin-0.02% EDTA solution (wt/vol). The flask was tapped to dislodge the cells, supplemented medium was added, and the cell suspension was pipetted again to produce a single-cell suspension. The cells were washed and resuspended in serum-free medium containing 5 mM L-arginine (saturated with 95% air and 5% CO 2 ) to the desired cell concentration. Cell viability was determined by trypan blue dye exclusion, and only single-cell suspensions of greater than 90% viability were used. To produce tumors, 1 × 10 5 tumor cells suspended in 0.1 mL of the above medium were injected subcutaneously into the flank of syngeneic C3H/HeN mice. For NO-mediated bystander antitumor activity, NO-producing C4.P cells and target cells were mixed at different ratios before injection. In some experiments, the NO-producing cells were injected into the left flank and the target cells were injected into the right flank. Tumors were measured by calipers twice a week. A tumor exceeding an average diameter (short and long diameters) of 3 mm was recorded as positive.
Fate of [ 125 I]IdUrd-Labeled Cells After Subcutaneous Injection
The C4.P cells were labeled with [ 125 I]IdUrd. Labeled C4.P cells (1 × 10 5 / mouse) were injected subcutaneously into unanesthetized C3H/HeN mice. At various intervals after subcutaneous injection, groups of mice (n ‫ס‬ 5 per time point) were killed. The injection site was resected and placed into a 50-mL test tube containing 70% ethanol. The ethanol was replaced daily for 3 days to remove all soluble 125 I released from dead cells (25) . The radioactivity in all of the samples was then determined in a gamma counter. Triplicate samples of the inoculum dose were monitored in parallel. The mean count in samples from each group of mice at each time point was expressed as the percentage of input counts. All measurements were corrected for radioactive decay of input cells (10, 25) .
Statistical Analysis
The differences in in vitro autocytolysis and cytostasis between NO-producing cells and control (NO-negative cells) and the differences in cytolysis of bystander cells mediated by NO-producing or control cells were analyzed for significance by the Student's t test (two-tailed). The differences in average tumor diameter or percent of surviving tumor cells were analyzed for significance by the Mann-Whitney U test.
Results
Autolysis of Tumor Cells Genetically Engineered to Produce NO
In the first set of experiments, the highly metastatic C4.P cells were transfected with either the functional full-length iNOS gene (piNOS-L8) or the control C-terminal-truncated iNOS gene (piNOS-S2) in the presence of 3 mM NMA (10) . The success of transfection was verified by northern and western blot analyses (data not shown). As reported previously (10) , in the absence of NMA, cells transfected with piNOS-S2 did not produce detectable NO, whereas several piNOS-L8-transfected clones produced various amounts of NO (Fig. 1, A) . Among the subclones tested, C4.L8.5 produced the highest levels of NO, peaking at 48 hours. By 96 hours, C4.L8.17 produced moderate levels and C4.L8.23 produced low levels of NO. All three clones grew well in medium containing 3 mM NMA.
We next cultured the transfectants in medium without NMA and monitored cytotoxicity. The data clearly showed a direct correlation between the level of NO production and cytotoxicity (Fig. 1, B and C) . C4.L8.5 cells produced the highest NO output and exhibited the highest cytostasis and cytolysis. The C4.L8.17 cells, which produced a moderate level of NO output, underwent statistically significant cytostasis but not cytolysis. The C4.L8.23 cells, which produced low levels of NO, underwent a low level of cytostasis but not cytolysis. The cytostasis of C4.L8.5, C4.L8.17, and C4.L8.23 cells was reversed by the presence of 3 mM NMA (Fig. 1, B) . The addition of 3 mM NMA reversed the cytolysis of only C4.L8.5 cells (Fig. 1, C) . 
Lysis of Bystander Cells by Tumor Cells Genetically Engineered to Produce NO
In the next set of experiments, we cultured the C4.L8. H]TdR-labeled C4.P parental cells for 72 hours in medium alone or medium containing 3 mM NMA. In the absence of NMA, only the C4.L8.5 cells produced significant lysis of the C4.P cells (Fig. 2, A) . The cytolysis of the bystander tumor cells was time dependent (Fig. 2, B) , and the higher C4.L8.5:C4 effector:target (E:T) ratios produced higher levels of lysis in the bystander cells (Fig. 2, C) . The data imply that the kinetics of NO production by the effector cells is critical to the production of lysis in the bystander cells. The lysis of bystander tumor cells was not unique to the C4.P tumor. We base this conclusion on the results of experiments in which we cocultured (Fig. 2, D) .
Tumorigenicity of NO-Producing C4.L8.5, C4.L8.17, and C4.L8.23 Cells
In the first set of in vivo experiments, we compared the tumorigenicity of the NO-producing C4.L8.5 cells with that of non-NO-producing C4.Neo3, C4.S2.3, and C4.P cells. C3H/ HeN mice (n ‫ס‬ 5) were inoculated subcutaneously with the different cell lines. Rapidly growing tumors developed in mice inoculated subcutaneously with C4.P, C4.Neo.3, or C4.S2.3 cells. In contrast, no palpable lesions were found in mice implanted subcutaneously with the C4.L8.5 cells (Fig. 3, A) . Even the injection of 1 × 10 5 C4.L8.5 cells did not produce palpable tumors by day 35 of the study (data not shown). The tumorigenicity of the C4.L8.17 and C4.L8.23 cells was also lower than that of the control cells (data not shown). To determine cell survival at the implantation site, we used [
125 I]IdUrd-labeled cells. A previous study (25) showed that, after subcutaneous injection, tumor cells die and that, by day 3 after injection, few to no cells are distributed to distant sites. As shown in Fig. 3 , B, by day 3 after injection, more than 20% of control cells (C4.P, C4.Neo3, and C4.L8.5) were viable. In contrast, the viability of C4.L8.5 cells was less than 2%. The decreased survival of C4.L8.5 cells was consistent with its decreased tumorigenicity (Fig. 3, A) .
Inhibition of Bystander Cell Tumorigenicity by Tumor Cells Engineered to Produce a High Output of NO
To determine whether NO released from tumor cells could affect the tumorigenicity of bystander tumor cells, C3H/HeN mice (n ‫ס‬ 10) received an injection of a mixture of C4.P cells with C4.L8.5 cells (high NO output) or C4.S2.3 cells (negative-NO output) (E:T ratio, 5:1). Mice that received an injection of C4.P cells developed tumors of 0.5 cm in diameter by day 19 . In mice that received a subcutaneous injection of C4.P cells ad- (Fig. 4, A) . The mixture of C4.P cells and C4.S2. 5 ) were injected subcutaneously into syngeneic C3H/HeN mice (n ‫ס‬ 5). Tumor size was monitored every 2-3 days. * ‫ס‬ Difference in C4.L8.5 tumor diameter differed significantly from that produced by the other cell types (P<.001). B) [ 125 I]iododeoxyuridinelabeled C4.P, C4.Neo3, C4.S2.3, and C4.L8.5 cells were injected subcutaneously into groups of syngeneic C3H/HeN mice (n ‫ס‬ 5). The mice were killed on day 2, and the number of viable cells was determined by monitoring the radioactivity in the injection site. * ‫ס‬ Number of surviving C4.L8.5 cells differed significantly from the other cell types (P<.001). This is one representative experiment of two performed. ) were injected subcutaneously into C3H/HeN mice (n ‫ס‬ 10) at the same or separate sites (L ‫ס‬ left flank; R ‫ס‬ right flank). Tumor size was monitored every 2-3 days. C4.L8.5 cells suppressed the growth of bystander C4.P tumor cells (P<.001) but did not affect the growth of C4.P cells injected at a distant subcutaneous site. * ‫ס‬ Diameter of tumors produced by C4.P cells admixed with C4.L8.5 cells differed significantly from that produced by C4.P cells and C4.L8.5 cells injected at two separate sites (P<.05). This is one representative experiment of two performed. C) Effector C4.L8.5 cells were mixed with [
125 I]iododeoxyuridine-labeled C4.P target cells (effector:target [E:T] ratio, 0:1 to 10:1) and injected subcutaneously into groups of syngeneic C3H/HeN mice (n ‫ס‬ 5). The mice were killed on day 4, and the number of viable C4.P cells was determined by monitoring the radioactivity at the injection site. * ‫ס‬ Number of surviving C4.P target cells admixed with effector C4.L8.5 cells differed significantly from that of C4.P cells injected alone. This is one representative experiment of two performed. D) Reversal of nitric oxide-mediated cytolysis by N G -methyl-L-arginine (NMA). Groups of mice were given a subcutaneous injection of a mixture of effector C4.L8.5 effector or C4.S2.3 cells and target C4.P cells (E:T ratio, 1:5). The mice also received twice-daily intraperitoneal injections of 10 mg NMA from day 1 to day 4. Control mice were injected with Hanks' balanced salt solution (HBSS). The mice were killed on day 4, and the number of viable C4.P cells was determined by monitoring the radioactivity at the injection site. * ‫ס‬ Number of surviving target cells admixed with C4.L8.5 cells differed significantly from that of C4.P cells admixed with C4.S2.3 cells (P<.01). This is one representative experiment of three performed.
(E:T ratio, 5:1) produced tumors with a median diameter of 0.6 ± 0.1 cm and 0.6 ± 0.2 cm, respectively (P<.05). Bystander inhibition required intimate contact with the C4.L8.5 cells: the subcutaneous injection of C4.P cells into one flank and C4.L8.5 cells into the other did not inhibit the tumorigenicity of the C4.P cells (Fig. 4, B) , indicating that the inhibition of C4.P cells by C4.L8.5 cells was local and not systemic.
In Vivo Cytolysis of Bystander Tumor Cells by NO-Producing Tumor Cells
To determine whether the inhibition of tumorigenicity of C4.P cells (or other tumor cells) by the NO-producing C4.L8.5 cells was due to cytostasis or cytolysis, we studied the fate of C4.P cells subsequent to subcutaneous implantation. C4.P cells labeled with [
125 I]IdUrd were injected subcutaneously into C3H/ HeN mice together with C4.L8.5 or C4.S2.3 cells. Cell survival was determined by monitoring the radioactivity of viable cells at the injection site (25) . By day 4 of the study, the NO-producing C4.L8.5 cells produced lysis of the bystander C4.P cells in a ratio-dependent manner (Fig. 4, C) . The survival of [
125 I]IdUrdlabeled cells directly correlated with growth of tumors (Fig. 4, A  and B) .
To confirm that NO production was directly responsible for the lysis of the [
125 I]IdUrd-labeled C4.P cells, we treated groups of mice (n ‫ס‬ 5) with twice-daily intraperitoneal injections of 10 mg/dose NMA (19) . The NMA treatment enhanced survival of the co-injected C4.P cells (Fig. 4, D) .
Discussion
The present results demonstrate that the transfection of highly metastatic C4.P cells (which express low levels of endogenous iNOS) with a full-length iNOS gene expression vector leads to constitutive NO production and autocytotoxicity in the absence of NMA, which was consistent with the previous findings from our laboratory and others (10, 26) . Under in vitro conditions, the iNOS-transfected cells also produced statistically significant lysis of a variety of bystander tumor cells in direct proportion to the level of NO. The finding that NMA inhibited NO production, autolysis, and lysis of bystander cells substantiated the role of NO in this process and further supports the findings that NO production might be sufficient to mediate in vitro cytotoxicity (10, 26) . The apparent bystander effect of NO against tumor cells is consistent with the finding that transfection of the iNOS gene and the production of NO suppress viral and bacterial replication within iNOS-negative neighboring cells (27) .
With the use of NMA, a specific iNOS inhibitor, we were able to isolate and maintain melanoma clones producing different levels of NO and to avoid possible phenotypic changes due to constant exposure to NO. The level of autolysis and lysis of bystander cells was directly related to the level and kinetics of NO production. The high-NO-output cells produced cytostasis and cytolysis in bystander cells, whereas the low-NO-output cells produced only cytostasis of bystander cells. These findings suggest that NO-mediated cytotoxicity occurs by cytostasis and that the induction of cytolysis requires a relatively high level of NO production within a short time.
Tumoricidal macrophages (5) and cytokine-activated endothelial cells (6,7) can produce lysis of tumor cells under in vitro conditions. The addition of NMA inhibits the destruction of certain types of tumor cells (5-7), suggesting that NO production by macrophages or endothelial cells plays a major role in the observed cytotoxicity. The present data show that tumor cells genetically engineered to produce NO can also lyse bystander cells. There are some differences, however, between the macrophage-mediated lysis of target cells and tumor cell-mediated lysis of bystander cells. Tumor cells that produced moderate levels of NO with similar kinetics for macrophages did not produce lysis of bystander tumor cells, whereas macrophages do. This difference may be due to efficient macrophage binding to target cells (28) or to the production of multiple cytotoxic molecules by activated macrophages (2, 4, 11) . Some molecules produced by macrophages may modulate cellular resistance mechanisms of target cells, e.g., superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, and glutathione (4,11), or modulate genes involved in apoptosis, e.g., p53 (29) . In addition, activated macrophages can also generate both NO and superoxide molecules that lead to the generation of peroxinitrite, a potent cytotoxic molecule for more efficient killing of target cells (4) .
The in vivo induction of cell death by NO-mediated pathways has not been studied in detail. This article provides direct evidence that cells that produce NO in vivo undergo autolysis and destroy bystander cells. The in vivo lysis of the bystander cells required direct contact with the NO-producing cells: When the C4.P and C4.L8.5 cells were implanted into separate subcutaneous sites, the growth of the C4.P cells was unimpeded. Slow release of NO might lead to marginal cytotoxicity in vitro but significant cell death did happen in vivo, indicating that efficient cytotoxicity might occur in vivo when other cytotoxic molecules are involved, which may support the theory of peroxinitrite formation from NO and superoxide (4) .
In summary, we show that tumor cells transfected with the enzymatically active iNOS gene produce high levels of NO, which produces autolysis and destruction of neighboring bystander cells. These data imply that the regression of neoplasms can occur by the activation of the iNOS gene in some, but not necessarily all, cells in the tumor tissue. Since NO-mediated cytotoxicity is nonspecific, targeting of the iNOS gene to only the neoplasms would be highly desirable.
